Funding round
Resilience Series B
Resilience, which works in biologics manufacturing in Blue Ash, raised $800M in a Series B round announced on 23 Nov 2020, led by ARCH Venture Partners and 8VC. 4 firms took part. It is Resilience's first venture round on record.
$800M
Amount raised
Not disclosed
Post-money valuation
4
Investors
2 leads
Valuation
What this round says about the price
Resilience did not disclose a valuation in this round. It is Resilience's first venture round on record, in the year it was founded (2020). It is 40% of the $2.02B Resilience has raised in the venture rounds on record. Resilience raised again 9 months later: a Series C round of $600M in Aug 2021.
Investors
Who put money in
ARCH Venture Partners and 8VC led the round with 2 other firms.
Lead investors
- ARCH Venture Partners backs 99 venture-backed companies new investor
- 8VC new investor
Also in the round
- GV backs 428 venture-backed companies new investor
- New Enterprise Associates backs 286 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development.
- Product development
Comparable rounds
How it compares
59 Series B rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $41M, and this round was 19 times the median. The closest in time, other companies' Series B rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 26 Nov 2020 | $13M | not disclosed | Vickers Venture Partners |
| Pharmaceutical Products | 8 Dec 2020 | $105M | not disclosed | Venrock |
| Pharmaceutical Products | 22 Dec 2020 | $47M | not disclosed | Bios Partners |
| Pharmaceutical Products | 14 Sep 2020 | $78M | not disclosed | Sanofi Ventures and Cowen Healthcare Investments |
| Pharmaceutical Products | 23 Sep 2020 | $60M | $161M | ARCH Venture Partners |
| Pharmaceutical Products | 7 Jan 2021 | $54M | not disclosed | RA Capital and Vivo Capital |
| Pharmaceutical Products | 8 Sep 2020 | $35M | not disclosed | Forbion |
| Pharmaceutical Products | 28 Sep 2020 | $21M | not disclosed | not named |
Sources
Where this comes from
Reported by 5 sources.
Questions
Frequently asked
How much did Resilience raise in its Series B round?
Resilience raised $800M in its Series B round, announced in Nov 2020.
Who led Resilience's Series B round?
ARCH Venture Partners and 8VC led it, with GV and New Enterprise Associates.
What was Resilience's valuation at the Series B round?
It was not disclosed.
How does it compare with other Series B rounds in Pharmaceutical Products?
59 Series B rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $41M, and this round was 19 times the median.
Did Resilience raise again after this round?
Yes: a Series C round in Aug 2021 of $600M.